Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CKPT

Checkpoint Therapeutics (CKPT) Stock Price, News & Analysis

Checkpoint Therapeutics logo

About Checkpoint Therapeutics Stock (NASDAQ:CKPT)

Key Stats

Today's Range
$4.26
$4.26
50-Day Range
$4.15
$4.29
52-Week Range
$2.06
$4.50
Volume
N/A
Average Volume
1.56 million shs
Market Capitalization
$370.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.33
Consensus Rating
Hold

Company Overview

Checkpoint Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
8th Percentile Overall Score

CKPT MarketRank™: 

Checkpoint Therapeutics scored higher than 8% of companies evaluated by MarketBeat, and ranked 939th out of 958 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Checkpoint Therapeutics has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.

  • Upside/Downside

    The consensus price target for Checkpoint Therapeutics is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Checkpoint Therapeutics has received no research coverage in the past 90 days.

  • Read more about Checkpoint Therapeutics' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Checkpoint Therapeutics is -2.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Checkpoint Therapeutics is -2.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Short Interest

    There is no current short interest data available for CKPT.
  • Dividend Yield

    Checkpoint Therapeutics does not currently pay a dividend.

  • Dividend Growth

    Checkpoint Therapeutics does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for CKPT.
    • Insider Buying vs. Insider Selling

      In the past three months, Checkpoint Therapeutics insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      Only 2.10% of the stock of Checkpoint Therapeutics is held by insiders.

    • Percentage Held by Institutions

      Only 22.00% of the stock of Checkpoint Therapeutics is held by institutions.

    • Read more about Checkpoint Therapeutics' insider trading history.
    Receive CKPT Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Checkpoint Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

    By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

    CKPT Stock News Headlines

    Bitcoin grabs headlines, but smart money likes this token
    If you're a futures trader (or want to be one), this could be the biggest shift you'll ever see in the prop firm world. Even if you have never explored prop trading, now is a great time to get started.tc pixel
    Checkpoint Therapeutics Announces Merger Progress
    See More Headlines

    CKPT Stock Analysis - Frequently Asked Questions

    Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) issued its earnings results on Tuesday, May, 13th. The company reported ($0.19) earnings per share for the quarter, missing analysts' consensus estimates of ($0.10) by $0.09.

    Checkpoint Therapeutics shares reverse split before market open on Sunday, December 4th 2022.The 1-10 reverse split was announced on Sunday, December 4th 2022. The number of shares owned by shareholders was adjusted after the market closes on Sunday, December 4th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Checkpoint Therapeutics investors own include TG Therapeutics (TGTX), Bionano Genomics (BNGO), Fortress Biotech (FBIO), NIO (NIO), uniQure (QURE), VBI Vaccines (VBIV) and Advanced Micro Devices (AMD).

    Company Calendar

    Last Earnings
    5/13/2025
    Today
    10/10/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    Pharmaceutical preparations
    Sub-Industry
    Pharmaceutical Products
    Current Symbol
    NASDAQ:CKPT
    CIK
    1651407
    Fax
    N/A
    Employees
    10
    Year Founded
    N/A

    Price Target and Rating

    High Price Target
    $4.80
    Low Price Target
    $4.10
    Potential Upside/Downside
    +1.7%
    Consensus Rating
    Hold
    Rating Score (0-4)
    2.33
    Research Coverage
    3 Analysts

    Profitability

    EPS (Trailing Twelve Months)
    ($1.29)
    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    -$51.85 million
    Net Margins
    N/A
    Pretax Margin
    -98,868.08%
    Return on Equity
    N/A
    Return on Assets
    -659.07%

    Debt

    Debt-to-Equity Ratio
    N/A
    Current Ratio
    0.29
    Quick Ratio
    0.29

    Sales & Book Value

    Annual Sales
    $41 thousand
    Price / Sales
    9,041.59
    Cash Flow
    N/A
    Price / Cash Flow
    N/A
    Book Value
    ($0.47) per share
    Price / Book
    -9.06

    Miscellaneous

    Outstanding Shares
    87,020,000
    Free Float
    47,808,000
    Market Cap
    $370.71 million
    Optionable
    Optionable
    Beta
    1.18
    7 Stocks to Ride The A.I. Megaboom Cover


    We are about to experience the greatest A.I. boom in stock market history...

    Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

    That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

    1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
    2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
    3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

    Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

    And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

    Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

    Get This Free Report

    This page (NASDAQ:CKPT) was last updated on 10/10/2025 by MarketBeat.com Staff
    From Our Partners